Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers.

52W Range

9thpctl

Volume

0.95×avg

Market Cap

39.60MUSD

P/E Ratio

-1.9TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Actuate Therapeutics Inc

ACTUNASDAQ Global Market·USD·Closed

Actuate Therapeutics Inc

ACTUNASDAQ·USD·Closed

$1.66

−2.07%

$1.66

−$0.03 (2.07%)

52W Range

9thpctl

Volume

0.95×avg

Mkt Cap

39.60MUSD

P/E

-1.9TTM

Div Yield

–ann

ACTU: Actuate Therapeutics Inc Stock Analysis | finqOS